Regiospecific total synthesis of juncusol
โ Scribed by Dale L. Boger; Michael D. Mullican
- Publisher
- Elsevier Science
- Year
- 1982
- Tongue
- French
- Weight
- 213 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0040-4039
No coin nor oath required. For personal study only.
โฆ Synopsis
A regiospecific total synthesis of juncusol (1) based on the use of two consecutive phenol annulations is detailed. A recent search for the antileukemic constituents in the extracts of needle rush, Juncus ~ roemerianus, resulted in the isolation and identification of juncusol (l_), a highly substituted 9,10-dihydrophenanthrene2 possessing modest antitumor and antimicrobial properties. The unusual structure of juncusol (JJ, its confirmed cytotoxic properties, and the notable lack of synthetic methodology capable of easily accommodating the aromatic substitution patterns found in this and related dihydrophenanthrenes have provided the incentive for much synthetic work in the interval since its initial identification.3'4'5 In recent communications we described the development of two different phenol annulations: the first based on the Robinson annulation of D-keto sulfoxides, equation 1, and the second based on the inverse electron demand Diels-Alder reaction of 3-carbomethoxy cc-pyrones with 1 ,l-dimethoxyethylene, ment of a conceptually eqn. 1 1 I J4 : OH equation 2." Herein we would like to disclose our efforts on the developsimple and regiospecific total synthesis of juncusol (1) based on the use eqn. 2 CH3OQCH R = C02CH3 R=H of two such phenol annulations, Scheme I. Implicit in the design of this approach is the ease
with which the substitution pattern of either phenol may be introduced or altered.
๐ SIMILAR VOLUMES
A recent communication by Miles et al. has described the structure of juncusol (11, a constituent of the extracts of the needlerush (Juncus roemerianus).' In view of the confirmed cytotoxic activity (ED50 = 0.3 ug/ml) of juncusol against the NC1 90 KEI human epidermoid carci-
Juncusol (7) has been prepared by a novel electrocyclization process beginning with the known &tetralone derivative 9.
The pioneering work of Wong et al in 1971-73' was the first of a growing series of investigations toward the efficient laboratory synthesis of clinically useful anthracycline antibiotics. Although several total syntheses of (\*)-daunomycinone (IIIa) and adriamycinone (IIIb) have been reported,' only